Expanding Access to Low-Cost Generics Act of 2019
USA116th CongressS-3092| Senate
| Updated: 12/18/2019
Tina Smith
Democratic Senator
Minnesota
Cosponsors (1)
Health, Education, Labor, and Pensions Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Expanding Access to Low-Cost Generics Act of 2019 This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Health
Civil actions and liabilityDrug safety, medical device, and laboratory regulationIntellectual propertyPrescription drugs
Expanding Access to Low-Cost Generics Act of 2019
USA116th CongressS-3092| Senate
| Updated: 12/18/2019
Expanding Access to Low-Cost Generics Act of 2019 This bill modifies the 180-day exclusivity period for certain generic drug manufacturers.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Tina Smith
Democratic Senator
Minnesota
Cosponsors (1)
Health, Education, Labor, and Pensions Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Civil actions and liabilityDrug safety, medical device, and laboratory regulationIntellectual propertyPrescription drugs